Oncology
Real-Patient Drug Testing
Patient-Derived Models
Functional 3D microtumors from real patient tissue — no hydrogels needed
Fast, Actionable Data
Go/no-go drug decisions delivered in just 4–6 weeks
Scalable Automation
Automated drug screening with AI analysis across dozens of compounds
Scientifically Validated
Trusted platform, backed by peer-reviewed science and clinical experts
Trusted by leading clinics and researchers in Switzerland and Germany.
How PreComb Accelerates Oncology Drug Development
From data to decisions – in two streamlined phases
What Researchers Say About PreComb
See what some of our leading research partners say about their experience with Precomb Assist.
“One of the biggest challenges in cancer research is bridging the gap between preclinical testing and real patient outcomes. PreComb’s approach addresses this challenge by providing patient-relevant, functional models that allow us to test therapies in a way that truly mimics human biology.“
Javad Nazarian
Professor University of Zurich, Head of DMG Research Center at University Children’s Hospital Zurich.
